Filings & corporate actions
- 31 OctresultsResults · Q2 FY27 · consolidated and standalone+1.7%NSE
- 14 OctshareholdingShareholding · 30 Sept 2026+2.5%NSE
- 9 OctresultsResults · Q4 FY26 · consolidated and standalone-1.7%NSE
- 30 JulresultsResults · Q1 FY27 · consolidated and standalone+0.3%NSE
- 21 JuldividendDividend · ₹3.50 per share-0.6%
- 14 JulshareholdingShareholding · 30 Jun 20260.0%NSE
- 24 MayresultsResults · Q4 FY26 · standalone-0.4%NSE
- 23 MayresultsResults · Q4 FY26 · consolidated-0.4%NSE
- 16 AprshareholdingShareholding · 31 Mar 2026-0.6%NSE
- 28 JanresultsResults · Q3 FY26 · consolidated and standalone-0.3%NSE
- 20 JanshareholdingShareholding · 31 Dec 2025-3.9%NSE
Reaction to results · all yearsrose on day 0 in 9 of 19 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q2 FY27 | 31 Oct 2026 | +1.7% | +4.2% | — | 1.9× |
| Q1 FY27 | 30 Jul 2026 | +0.3% | +2.4% | -5.1% | 2.3× |
| Q4 FY26 | 23 May 2026 | -0.4% | -1.0% | +6.3% | 1.0× |
| Q3 FY26 | 28 Jan 2026 | -0.3% | -5.5% | +1.9% | 0.8× |
| Q2 FY26 | 13 Nov 2025 | -1.0% | -1.9% | +2.1% | 0.9× |
| Q1 FY26 | 26 Jul 2025 | -1.0% | -3.5% | -3.1% | 0.5× |
| Q4 FY25 | 24 May 2025 | +0.4% | +1.6% | +8.7% | 1.0× |
| Q3 FY25 | 10 Feb 2025 | -1.0% | -6.3% | -9.7% | 1.6× |
| Q2 FY25 | 28 Oct 2024 | -2.0% | +3.4% | +1.8% | 3.4× |
| Q1 FY25 | 13 Aug 2024 | +1.6% | +0.8% | +9.0% | 0.6× |
| Q4 FY24 | 20 May 2024 | -4.7% | -9.0% | -6.9% | 0.6× |
| Q3 FY24 | 25 Jan 2024 | -0.5% | -3.4% | +4.7% | 0.6× |
| Q2 FY24 | 31 Oct 2023 | -6.5% | -11.2% | -5.5% | 3.5× |
| Q1 FY24 | 8 Aug 2023 | -2.1% | -3.5% | -4.1% | 0.5× |
| Q4 FY23 | 15 May 2023 | +5.0% | +5.1% | +9.3% | 3.5× |
| Q3 FY23 | 9 Feb 2023 | +2.2% | +3.2% | -4.5% | 0.6× |
| Q2 FY23 | 6 Nov 2022 | +4.7% | +7.3% | -6.0% | 2.7× |
| Q1 FY23 | 9 Aug 2022 | +12.5% | +22.5% | +26.4% | 17.8× |
| Q4 FY22 | 30 May 2022 | +0.6% | -3.0% | -4.5% | — |
| Average | +0.5% | +0.1% | +1.1% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q2 FY27
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | +16.2% | +15.7% | — | — | — | — |
| Profit | +12.4% | +10.7% | — | — | — | — |
Key data
Delivery percentage
Over the last 20 sessions RAINBOW settled 54.8% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 56.7%. The latest session ranks higher than 32% of the 1,124 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
Dividends, deals & holders
Performance returns
| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | +1.52% | -0.93% | +5.00% | -13.33% | -6.33% | -6.10% |
Valuation
Ownership
Quarterly results · consolidated
| Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 445.4 | 459.9 | 470.0 | 548.0 |
| YoY chg | +11.9% | +24.3% | +33.2% | +23.2% |
| Net profit (₹ Cr) | 73.9 | 78.2 | 62.5 | 83.9 |
| YoY chg | +7.2% | +38.3% | +16.2% | +10.9% |
| Net margin | 16.6% | 17.0% | 13.3% | 15.3% |
| EPS | 7.14 | 7.59 | 5.97 | 8.10 |
Shareholding over time
By quarter
30 Sept 2026 · promoter 49.83% · public 49.77%- Promoter
- Public and others
- Promoter
- 49.83%
- Public
- 49.77%
- Promoter change
- -0.01 pp
- Filed
- 14 Oct 2026
- FII
- 14.66%
- DII
- 23.28%
- Promoter pledged
- 0.00%
Who the public is
- Mutual funds
- 18.84%
- Insurance
- 2.76%
- FPI
- 14.66%
- Retail ≤ ₹2L
- 5.53%
- HNI > ₹2L
- 5.21%
- NRI
- 0.29%
- Bodies corporate
- 0.63%
- Shareholders
- 92,814
+0.31 pp QoQ
+0.08 pp QoQ
-1.37 pp QoQ
+0.40 pp QoQ
-0.07 pp QoQ
+0.03 pp QoQ
+0.03 pp QoQ
+3.9% QoQ
Major holders
As of 30 Sept 2026| Holder | Type | Holding | Shares |
|---|---|---|---|
| RAMESH KANCHARLA | Promoter · Individual | 31.03% | 3.15Cr |
| CHIRLA DINESH KUMAR PADMARAO | Promoter · Individual | 6.53% | 66.33L |
| ADARSH KANCHARLA | Promoter · Individual | 6.02% | 61.10L |
| ICICI PRUDENTIAL HEALTHCARE FUND | Mutual fund | 5.50% | 55.82L |
| RAMESH KANCHARLA | Promoter · Other | 5.13% | 52.06L |
| DSP FLEXI CAP FUND | Mutual fund | 3.42% | 34.78L |
| FRANKLIN TEMPLETON INVESTMENT FUNDS - FRANKLIN IND | FPI | 2.20% | 22.32L |
| HDFC LIFE INSURANCE COMPANY LIMITED | Insurance | 2.10% | 21.38L |
| ABU DHABI INVESTMENT AUTHORITY - MONSOON | FPI | 2.06% | 20.91L |
| TITANIUM EQUITY LONG-SHORT FUND | Mutual fund | 1.88% | 19.13L |
Every promoter-group member, and each public holder above 1%, as filed.
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.
Dividends
| Financial year | Payments | Declared | Adjusted |
|---|---|---|---|
| FY2026-27 | 1 | ₹3.50 | ₹3.50 |
| FY2025-26 | 1 | ₹3.00 | ₹3.00 |
| FY2024-25 | 1 | ₹3.00 | ₹3.00 |
| FY2023-24 | 1 | ₹3.00 | ₹3.00 |
| FY2022-23 | 1 | ₹2.00 | ₹2.00 |
| Ex-date | Record date | Declared | Adjusted |
|---|---|---|---|
| 21 Jul 2026 | — | ₹3.50 | ₹3.50 |
| 27 Jun 2025 | — | ₹3.00 | ₹3.00 |
| 23 Jul 2024 | — | ₹3.00 | ₹3.00 |
| 22 Jun 2023 | — | ₹3.00 | ₹3.00 |
| 7 Sept 2022 | — | ₹2.00 | ₹2.00 |
Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.
Insider trades
- Insiders net, 30d
- ₹0
- Insiders net, 90d
- ₹0
- Promoters net, 90d
- ₹0
- Insider buyers, 90d
- 0
- Last promoter buy
- 2.5 years ago
- Disclosures on record
- 36
| Broadcast | Person | Side | Shares | Value | Price | Holding before → after | Stake | Regulation |
|---|---|---|---|---|---|---|---|---|
| 6 Nov 2024 | Dr. Prashanth KEmployee | Sell | 10.0K | ₹1.6Cr | 1,603.98 | 20.0K → 10.0K | 0.01%-0.01 pp | 7(2)told 4 Nov 2024 |
| 6 Nov 2024 | Dr. Pranathi Subrahmanyam MaddiralaEmployee | Sell | 10.0K | ₹1.6Cr | 1,568.20 | 4.16L → 4.06L | 0.40%-0.01 pp | 7(2)told 4 Nov 2024 |
| 30 Sept 2024 | Dr. Pranathi Subrahmanyam MaddiralaEmployee | Sell | 5.0K | ₹71.5L | 1,430.64 | 4.21L → 4.16L | 0.41%-0.00 pp | 7(2)told 27 Sept 2024 |
| 20 Sept 2024 | Dr. Preetham Kumar PoddutoorEmployee | Sell | 3.5K | ₹47.3L | 1,352.02 | 11.58L → 11.54L | 1.14%-0.00 pp | 7(2)told 20 Sept 2024 |
| 19 Sept 2024 | Dr. Preetham Kumar PoddutoorEmployee | Sell | 15.6K | ₹2.0Cr | 1,307.33 | 11.73L → 11.58L | 1.14%-0.02 pp | 7(2)told 19 Sept 2024 |
| 19 Sept 2024 | Dr. Shruthi Reddy PoddutoorEmployee | Sell | 15.0K | ₹2.0Cr | 1,325.95 | 30.0K → 15.0K | 0.01%-0.01 pp | 7(2)told 17 Sept 2024 |
| 17 Sept 2024 | Dr. Pranathi Subrahmanyam MaddiralaEmployee | Sell | 5.0K | ₹66.8L | 1,335.02 | 4.26L → 4.21L | 0.41%-0.00 pp | 7(2)told 14 Sept 2024 |
| 21 Aug 2024 | Dr. Preetham Kumar PoddutoorEmployee | Sell | 7.0K | ₹83.7L | 1,195.55 | 11.80L → 11.73L | 1.16%-0.01 pp | 7(2)told 20 Aug 2024 |
| 21 Aug 2024 | Dr. Pranathi Subrahmanyam MaddiralaEmployee | Sell | 19.7K | ₹2.3Cr | 1,184.91 | 4.46L → 4.26L | 0.42%-0.02 pp | 7(2)told 19 Aug 2024 |
| 29 May 2024 | Kancharla Family Trust (Through Dr. Ramesh kancharla)Promoter | Buy | 26.5K | ₹3.3Cr | 1,235.25 | 51.79L → 52.06L | 5.13%+0.03 pp | 7(2)told 28 May 2024 |
| 29 May 2024 | Dr. Ramesh KancharlaPromoter | Buy | 22.8K | ₹2.8Cr | 1,225.43 | 3.15Cr → 3.15Cr | 31.05%+0.02 pp | 7(2)told 28 May 2024 |
| 30 Mar 2024 | Dr. Pranathi Subrahmanyam MaddiralaEmployee | Sell | 4.0K | ₹50.0L | 1,250.77 | 4.50L → 4.46L | 0.44%-0.00 pp | 7(2)told 30 Mar 2024 |
| 5 Mar 2024 | Dr. Maddirala SubrahmanyamRelative | Sell | 800 | ₹11.3L | 1,407.89 | 1.5K → 700 | 0.00%0.00 pp | 7(2)told 2 Mar 2024 |
| 23 Feb 2024 | Varikutti Madhu BabuEmployee | Sell | 4.5K | ₹56.7L | 1,259.65 | 5.0K → 500 | 0.00%0.00 pp | 7(2)told 21 Feb 2024 |
| 25 Aug 2023 | Kalyani NuluEmployee | Sell | 2.3K | ₹26.0L | 1,147.09 | 2.3K → — | 0.00% | 7(2)told 24 Aug 2023 |
| 24 Jun 2023 | Dr. Preetham Kumar PoddutoorEmployee | Sell | 5.1K | ₹49.4L | 975.18 | 11.85L → 11.80L | 1.16%-0.00 pp | 7(2)told 23 Jun 2023 |
| 21 Jun 2023 | R GowrisankarEmployee | Sell | 1.5K | ₹14.5L | 966.00 | 40.5K → 39.0K | 0.04%-0.00 pp | 7(2)told 21 Jun 2023 |
| 8 Jun 2023 | Saurabh Anand BhandariEmployee | Sell | 9.8K | ₹91.5L | 938.15 | 10.0K → 250 | 0.00%0.00 pp | 7(2)told 8 Jun 2023 |
| 8 Jun 2023 | Mahesh MadduriEmployee | Sell | 49.0K | ₹4.5Cr | 928.02 | 50.0K → 1.0K | 0.00%0.00 pp | 7(2)told 7 Jun 2023 |
| 22 May 2023 | Ranjini NairEmployee | Sell | 10.0K | ₹92.3L | 923.41 | 10.2K → 216 | 0.00%0.00 pp | 7(2)told 19 May 2023 |
| 22 May 2023 | Varikutti Madhu BabuEmployee | Sell | 1.3K | ₹12.4L | 921.69 | 6.5K → 5.2K | 0.01%-0.00 pp | 7(2)told 19 May 2023 |
| 23 Mar 2023 | Dr. Preetham Kumar PoddutoorEmployee | Sell | 4.0K | ₹29.6L | 740.69 | 11.89L → 11.85L | 1.17%-0.00 pp | 7(2)told 22 Mar 2023 |
| 7 Mar 2023 | Dr. Preetham Kumar PoddutoorEmployee | Sell | 1.9K | ₹14.1L | 739.84 | 11.91L → 11.89L | 1.17%-0.00 pp | 7(2)told 6 Mar 2023 |
| 2 Mar 2023 | Dr. Preetham Kumar PoddutoorEmployee | Sell | 5.4K | ₹39.4L | 729.11 | 11.97L → 11.91L | 1.17%-0.01 pp | 7(2)told 1 Mar 2023 |
| 24 Feb 2023 | Dr. Preetham Kumar PoddutoorEmployee | Sell | 2.6K | ₹19.8L | 755.56 | 11.99L → 11.97L | 1.18%-0.00 pp | 7(2)told 23 Feb 2023 |
| 20 Feb 2023 | Dr. Preetham Kumar PoddutoorEmployee | Sell | 2.1K | ₹16.2L | 770.68 | 12.01L → 11.99L | 1.18%-0.00 pp | 7(2)told 20 Feb 2023 |
| 20 Feb 2023 | Dr. Shaik Farhan Abdur RashidEmployee | Sell | 6.2K | ₹47.6L | 768.00 | 4.00L → 3.94L | 0.39%-0.01 pp | 7(2)told 17 Feb 2023 |
| 20 Feb 2023 | Varikutti Madhu BabuEmployee | Sell | 2.0K | ₹15.2L | 761.92 | 8.5K → 6.5K | 0.01%-0.00 pp | 7(2)told 17 Feb 2023 |
| 18 Nov 2022 | Varikutti Madhu BabuEmployee | Sell | 2.0K | ₹17.4L | 871.45 | 10.5K → 8.5K | 0.01%-0.00 pp | 7(2)told 17 Nov 2022 |
| 18 Nov 2022 | Jayadeep Reddy JammuladinneEmployee | Sell | 3.9K | ₹33.9L | 865.97 | 3.9K → — | 0.00% | 7(2)told 17 Nov 2022 |
| 16 Nov 2022 | Dr. Pranathi Subrahmanyam MaddiralaEmployee | Sell | 10.0K | ₹81.9L | 819.42 | 4.60L → 4.50L | 0.44%-0.01 pp | 7(2)told 15 Nov 2022 |
| 14 Nov 2022 | Dr. Maddirala SubrahmanyamRelative | Sell | 15.0K | ₹1.2Cr | 794.06 | 15.0K → — | 0.00% | 7(2)told 10 Nov 2022 |
| 14 Nov 2022 | Jayadeep Reddy JammuladinneEmployee | Sell | 3.0K | ₹25.5L | 849.40 | 6.9K → 3.9K | 0.00%0.00 pp | 7(2)told 10 Nov 2022 |
| 14 Nov 2022 | Dr. Pranathi Subrahmanyam MaddiralaEmployee | Sell | 40.5K | ₹3.4Cr | 843.63 | 5.01L → 4.60L | 0.45%-0.04 pp | 7(2)told 10 Nov 2022 |
SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.
How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session
Bulk & block deals · 15 Sept 2023
CSV| Date | Deal | Client | Quantity | Price | Value |
|---|---|---|---|---|---|
| 15 Sept 2023 | Sell · bulk | BNP PARIBAS ARBITRAGE | 6.55L | 1,023.22 | ₹67.0Cr |
| 15 Sept 2023 | Buy · bulk | BNP PARIBAS ARBITRAGE | 1.6K | 1,025.22 | ₹16.1L |
| 5 Dec 2022 | Sell · bulk | CDC GROUP PLC | 96.33L | 735.55 | ₹708.5Cr |
| 5 Dec 2022 | Sell · bulk | CDC INDIA OPPORTUNITIES LIMITED | 50.33L | 735.00 | ₹369.9Cr |
| 5 Dec 2022 | Buy · bulk | STICHTING DEPOSITARY APG EMERGING MARKETS EQUITY POOL | 15.11L | 735.00 | ₹111.1Cr |
| 5 Dec 2022 | Buy · bulk | GOVERNMENT OF SINGAPORE | 14.46L | 735.00 | ₹106.3Cr |
| 5 Dec 2022 | Buy · bulk | ICICI PRUDENTIAL MUTUAL FUND | 12.54L | 735.00 | ₹92.2Cr |
| 5 Dec 2022 | Buy · bulk | ABU DHABI INVESTMENT AUTHORITY | 9.00L | 741.25 | ₹66.7Cr |
| 5 Dec 2022 | Buy · bulk | STICHTING DEPOSITARY APG EMERGING MARKETS EQUITY POOL | 7.45L | 735.00 | ₹54.8Cr |
| 5 Dec 2022 | Buy · bulk | INDIA ACORN ICAV - ASHOKA INDIA OPPORTUNITIES FUND | 7.22L | 735.00 | ₹53.1Cr |
| 5 Dec 2022 | Buy · bulk | GOVERNMENT OF SINGAPORE | 6.64L | 735.00 | ₹48.8Cr |
| 5 Dec 2022 | Buy · bulk | ICICI PRUDENTIAL MUTUAL FUND | 5.16L | 735.00 | ₹37.9Cr |
A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.
Takeover-code disclosures
Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.
Every stock on this session →Short selling, lending & margin
Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.
Exchange surveillance
No surveillance measure applies to RAINBOW.
Price band: 20% · not in the F&O ban.
From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.
Every stock on this session →Financials · quarterly statement
| Q3 FY24 | Q4 FY24A | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25A | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26A | Q1 FY27 | Q2 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 336.0 | 341.1 | 330.2 | 417.5 | 398.1 | 370.1 | 352.9 | 444.8 | 445.4 | 459.9 | 470.0 | 548.0 | |
| Other income | 8.6 | 12.8 | 11.9 | 11.3 | 13.3 | 14.5 | 20.0 | 8.2 | 10.5 | 5.1 | 12.7 | 8.1 | |
| Total income | 344.6 | 353.9 | 342.2 | 428.7 | 411.4 | 384.6 | 372.9 | 453.0 | 456.0 | 465.0 | 482.7 | 556.1 | |
| Total expenses | 259.8 | 284.7 | 288.8 | 323.4 | 317.0 | 307.7 | 301.6 | 350.6 | 358.3 | 376.6 | 398.7 | 444.6 | |
| └ Finance costs | 14.3 | 16.8 | 18.2 | 18.1 | 18.1 | 18.1 | 18.1 | 18.8 | 20.2 | 20.5 | 21.2 | 22.0 | |
| └ Depreciation | 27.7 | 32.3 | 34.1 | 34.9 | 35.2 | 34.2 | 34.2 | 35.8 | 39.6 | 40.9 | 42.2 | 44.6 | |
| Profit before tax | 84.8 | 69.2 | 53.4 | 105.4 | 94.3 | 77.0 | 71.4 | 102.4 | 97.7 | 86.8 | 84.0 | 111.5 | |
| Tax expense | 22.2 | 18.1 | 13.6 | 26.3 | 25.4 | 20.4 | 17.6 | 26.7 | 23.8 | 8.6 | 21.4 | 27.6 | |
| Net profit | 62.6 | 51.1 | 39.7 | 79.0 | 68.9 | 56.6 | 53.8 | 75.6 | 73.9 | 78.2 | 62.5 | 83.9 | |
| EPS | 6.12 | 5.02 | 3.89 | 7.77 | 6.76 | 5.55 | 5.27 | 7.41 | 7.14 | 7.59 | 5.97 | 8.10 | |
| Net margin | 18.63% | 14.97% | 12.03% | 18.93% | 17.32% | 15.28% | 15.25% | 17.00% | 16.59% | 17.01% | 13.31% | 15.31% | |
| PBT margin | 25.23% | 20.28% | 16.16% | 25.24% | 23.70% | 20.80% | 20.22% | 23.01% | 21.93% | 18.87% | 17.86% | 20.35% | |
| Tax rate | 26.18% | 26.18% | 25.54% | 25.01% | 26.91% | 26.52% | 24.62% | 26.13% | 24.36% | 9.88% | 25.51% | 24.76% |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 31 Oct 2026.
Balance sheet & cash flow · half-yearly
Balance sheet
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1,776.3 | 1,897.5 | 2,170.4 | 2,261.9 | 2,377.0 | 2,586.7 | 2,774.8 | 2,958.6 | |
| Current assets | 483.6 | 558.5 | 621.6 | 685.4 | 832.4 | 742.3 | 662.9 | 766.7 | |
| └ Cash & equivalents | 15.4 | 12.9 | 10.1 | 15.3 | 20.3 | 26.8 | 33.9 | 32.6 | |
| └ Other bank balances | 30.1 | 19.4 | 0.0 | 12.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| └ Current investments | 58.1 | 146.7 | 307.5 | 423.1 | 570.7 | 415.5 | 404.5 | 353.6 | |
| └ Trade receivables | 58.3 | 64.8 | 70.4 | 94.9 | 77.3 | 107.3 | 103.2 | 133.4 | |
| └ Inventories | 18.8 | 17.2 | 24.0 | 28.0 | 27.6 | 40.3 | 41.6 | 53.7 | |
| Total equity | 1,064.9 | 1,144.8 | 1,264.9 | 1,349.8 | 1,475.0 | 1,532.9 | 1,663.6 | 1,735.9 | |
| └ Attributable to owners | 1,059.9 | 1,139.4 | 1,258.9 | 1,343.4 | 1,468.2 | 1,517.9 | 1,648.1 | 1,714.0 | |
| └ Non-controlling interest | 5.0 | 5.4 | 6.0 | 6.3 | 6.8 | 15.0 | 15.5 | 21.9 | |
| └ Share capital | 101.5 | 101.5 | 101.5 | 101.6 | 101.6 | 101.6 | 101.6 | 101.6 | |
| Borrowings | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| └ Current | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| └ Non-current | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Trade payables | 84.5 | 75.4 | 81.5 | 100.9 | 91.0 | 129.3 | 100.6 | 126.6 | |
| Current liabilities | 144.4 | 127.0 | 149.5 | 159.6 | 150.6 | 208.4 | 184.5 | 218.5 | |
| Total liabilities | 711.4 | 752.8 | 905.5 | 912.2 | 902.0 | 1,053.7 | 1,111.3 | 1,222.7 | |
| Net debt | (103.6) | (179.1) | (317.6) | (450.5) | (591.0) | (442.4) | (438.4) | (386.2) | |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Current ratio | 3.35 | 4.40 | 4.16 | 4.30 | 5.53 | 3.56 | 3.59 | 3.51 |
Cash flow, year to date
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 327.2 | 151.7 | 321.4 | 192.8 | 395.7 | 207.6 | 419.7 | 217.8 | |
| └ Capex | (141.3) | (242.5) | (353.6) | (80.2) | (145.7) | (302.3) | (216.5) | (138.2) | |
| Free cash flow | 185.9 | (90.9) | (32.2) | 112.7 | 250.0 | (94.7) | 203.2 | 79.6 | |
| Investing cash flow | (465.2) | (91.9) | (226.5) | (114.3) | (267.8) | (124.8) | (258.6) | (86.9) | |
| Financing cash flow | 143.4 | (63.8) | (101.8) | (73.3) | (117.7) | (76.2) | (147.4) | (132.2) | |
| └ Dividends paid | (20.3) | (30.8) | (30.8) | (30.5) | (30.5) | (30.5) | (30.5) | (35.5) | |
| └ Buybacks | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net change in cash | 5.4 | (4.1) | (6.8) | 5.2 | 10.1 | 6.6 | 13.6 | (1.3) |
From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.
Announcements & board meetings
As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.
Every stock on this session →RAINBOW at a glance
- RAINBOW closed at ₹1,259.7 on 20 Nov 2026, +1.52% on the day, -6.1% over one year, 21.8% below its 52-week high of ₹1,610.
- Delivery was 47.5% of traded quantity on 20 Nov 2026, the 32nd percentile of its own 1,124 sessions with a reading (20-session average 54.8%, 1-year average 56.7%).
- Market capitalisation is ₹12,794 crore at a trailing P/E of 43.8 (trailing EPS ₹28.77).
- Q2 FY27 results (consolidated, filed 31 Oct 2026): revenue ₹548 crore (+23.2% year on year), net profit ₹84 crore (+10.9%); the price moved +1.7% on the first session after.
- Promoters held 49.83% at 30 Sept 2026, down 0.01 percentage points on the previous filing.
- Q3 FY27 results are expected between 25 Jan 2027 and 10 Feb 2027, going by past filing dates — an estimate, not an announcement.
About
Sector history
- to 16 Aug 2026Index industry · Healthcare
- from 16 Aug 2026Healthcare › Healthcare › Healthcare Services › Hospital
NSE’s own classification, by the snapshot it changed on.
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.
More in Healthcare Services
- APAPOLLOHOSPApollo Hospitals Enterprise Limited9,200.00+5.29%
- MAMAXHEALTHMax Healthcare Institute Limited1,081.00+3.88%
- PAPARASHLTHPARASHLTH844.65+1.16%
- FOFORTISFortis Healthcare Limited825.00+1.87%
- SYSYNGENESyngene International Limited451.70+3.28%
- ASASTERDMAster DM Quality Care Limited779.30+5.41%
- MAMANIPALHOSManipal Health Enterprises Limited702.20+0.83%
- LALALPATHLABDr. Lal Path Labs Ltd.2,006.00+2.18%
- THTHYROCAREThyrocare Technologies Limited528.45+4.67%
- ININDGNIndegene Limited657.65+1.90%
- MEMEDANTAGlobal Health Limited1,480.20+0.13%
- NHNHNarayana Hrudayalaya Ltd.1,943.70+3.77%
All Healthcare Services stocks on the NSEAll Healthcare stocks on the NSE